11. Phase III randomized study of carboplatin pemetrexed with or without bevacizumab with initial versus "at progression" cerebral radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis. (April 2021) Authors: Monnet, Isabelle; Vergnenègre, Alain; Robinet, Gilles; Berard, Henri; Lamy, Regine; Falchero, Lionel; Vieillot, Sabine; Schott, Roland; Ricordel, Charles; Chouabe, Stephane; Thomas, Pascal; Gervais, Radj; Madroszyk, Anne; Abdiche, Samir; Chiappa, Anne Marie; Greillier, Laurent; Decroisette, Chant... Journal: Therapeutic advances in medical oncology Issue: Volume 13(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Recurrent anaphylaxis to a gelatin-based colloid plasma substitute and to cetuximab following sensitisation to galactose-alpha-1, 3-galactose. (June 2021) Authors: Serrier, Julien; Khoy, Kathy; Ollivier, Yann; Gervais, Radj; Le Moel, Gabriel; Lafosse, Marion; Johnson, Alison; Le Mauff, Brigitte; Mariotte, Delphine Journal: British journal of anaesthesia Issue: Volume 126:Number 6(2021) Page Start: e200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Renal insufficiency is the leading cause of double maintenance (bevacizumab and pemetrexed) discontinuation for toxicity to advanced non-small cell lung cancer in real world setting. Issue 2 (August 2015) Authors: Sassier, Marion; Dugué, Audrey Emmanuelle; Clarisse, Bénédicte; Lesueur, Paul; Avrillon, Virginie; Bizieux-Thaminy, Acya; Auliac, Jean-Bernard; Kaluzinski, Laure; Tillon, Julie; Robinet, Gilles; Le Caer, Hervé; Monnet, Isabelle; Madroszyk, Anne; Boza, Gabriella; Falchero, Lionel; Fournel, Pierre;... Journal: Lung cancer Issue: Volume 89:Issue 2(2015:Aug.) Page Start: 161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Review of the Mechanisms Involved in the Abscopal Effect and Future Directions with a Focus on Thymic Carcinoma. Issue 3 (May 2017) Authors: Lesueur, Paul; Chevalier, François; Stefan, Dinu; Habrand, Jean-Louis; Lerouge, Delphine; Gervais, Radj Journal: Tumori Issue: Volume 103:Issue 3(2017) Page Start: 217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Risk factors associated with hypersensitivity reactions to cetuximab: anti-cetuximab IgE detection as screening test. (November 2014) Authors: Dupont, Benoît; Mariotte, Delphine; Clarisse, Bénédicte; Galais, Marie-Pierre; Bouhier-Leporrier, Karine; Grellard, Jean-Michel; Le Mauff, Brigitte; Reimund, Jean-Marie; Gervais, Radj Journal: Future oncology Issue: Volume 10:Number 14(2014) Page Start: 2133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Safety of combined PD‐1 pathway inhibition and radiation therapy for non‐small‐cell lung cancer: A multicentric retrospective study from the GFPC. (11th October 2018) Authors: Lesueur, Paul; Escande, Alexandre; Thariat, Juliette; Vauléon, Enora; Monnet, Isabelle; Cortot, Alexis; Lerouge, Delphine; Danhier, Serge; Dô, Pascal; Dubos‐Arvis, Catherine; Chouaïd, Christos; Gervais, Radj Journal: Cancer medicine Issue: Volume 7:Number 11(2018:Nov.) Page Start: 5505 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Successful treatment with ceritinib after crizotinib induced hepatitis. (May 2016) Authors: Sassier, Marion; Mennecier, Bertrand; Gschwend, Anthony; Rein, Mikahl; Coquerel, Antoine; Humbert, Xavier; Alexandre, Joachim; Fedrizzi, Sophie; Gervais, Radj Journal: Lung cancer Issue: Volume 95(2016) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Tailoring maintenance chemotherapy upon response to induction chemotherapy as compared with pemetrexed continuation maintenance in advanced non-squamous NSCLC patients: Results of the IFCT-GFPC-1101 multicenter randomized phase III trial. (February 2022) Authors: Souquet, Pierre-Jean; Audigier-Valette, Clarisse; Molinier, Olivier; Cortot, Alexis; Margery, Jacques; Moreau, Lionel; Gervais, Radj; Barlesi, Fabrice; Pichon, Eric; Zalcman, Gérard; Dumont, Patrick; Girard, Nicolas; Poudenx, Michel; Mazières, Julien; Cadranel, Jacques; Debieuvre, Didier; Dauba, ... Journal: Lung cancer Issue: Volume 164(2022) Page Start: 84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial. Issue 2 (February 2016) Authors: Quoix, Elisabeth; Lena, Hervé; Losonczy, Gyorgy; Forget, Frédéric; Chouaid, Christos; Papai, Zsolt; Gervais, Radj; Ottensmeier, Christian; Szczesna, Aleksandra; Kazarnowicz, Andrzej; Beck, Joseph T; Westeel, Virginie; Felip, Enriqueta; Debieuvre, Didier; Madroszyk, Anne; Adam, Julien; Lacoste, Gi... Journal: Lancet oncology Issue: Volume 17:Issue 2(2016:Feb.) Page Start: 212 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial. (4th November 2015) Authors: Nemunaitis, John; Papai, Zsolt; Léna, Hervé; Losonczy, Gyorgy; Forget, Frederic; Chouaid, Christos; Szczesna, Alexandra; Gervais, Radj; Ottensmeier, Christian H; Beck, Joseph; Kazarnowicz, Andrzej; Westeel, Virginie; Debieuvre, Didier; Madroszyk, Anne; Felip, Enriqueta; Limacher, Jean Marc; Quoix... Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗